Loss of caspase 7 expression is associated with poor prognosis in renal cell carcinoma clear cell subtype

Urology

Volumn 82, Issue 4, 2013, Pages 974.e1-974.e7

  Vilella Arias, Santiago A ^a,b   Rocha, Rafael Malagoli ^a,b   Da Costa, Walter Henriques ^a,b   Zequi, Stênio De Cássio ^a,b   Guimarães, Gustavo Cardoso ^a,b   Verjovski Almeida, Sergio ^a,b   Soares, Fernando A ^a,b   Reis, Eduardo M ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CASPASE 7; CASPASE 7 ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CANCER SURGERY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; HYBRIDIZATION; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY CARCINOMA; KIDNEY PARENCHYMA; KIDNEY VEIN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEPHRECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY; TISSUE SECTION; TUMOR INVASION; TUMOR NECROSIS;

EID: 84884987889     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2013.06.026     Document Type: Article

References (30)

1. B.I. Rini, S.C. Campbell, and B. Escudier Renal cell carcinoma Lancet 373 2009 1119 1132
2. A. Lopez-Beltran, J.C. Carrasco, and L. Cheng 2009 update on the classification of renal epithelial tumors in adults Int J Urol 16 2009 432 443
3. V. Ficarra, L. Schips, and F. Guille Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized renal cell carcinoma Cancer 104 2005 968 974
4. G. Novara, V. Ficarra, and A. Antonelli Validation of the 2009 TNM version in a large multi-institutional cohort of patients treated for renal cell carcinoma: are further improvements needed? Eur Urol 58 2010 588 595
5. V. Ficarra, G. Martignoni, and N. Maffei Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma Cancer 103 2005 68 75
6. M. Sun, G. Lughezzani, and C. Jeldres A proposal for reclassification of the Fuhrman grading system in patients with clear cell renal cell carcinoma Eur Urol 56 2009 775 781
7. C. Eichelberg, K. Junker, and B. Ljungberg Diagnostic and prognostic molecular markers for renal cell carcinoma: a critical appraisal of the current state of research and clinical applicability Eur Urol 55 2009 851 863
8. H.S. Tunuguntla, and M. Jorda Diagnostic and prognostic molecular markers in renal cell carcinoma J Urol 179 2008 2096 2102
9. M. Takahashi, D.R. Rhodes, and K.A. Furge Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification Proc Natl Acad Sci U S A 98 2001 9754 9759
10. L.S. Liou, T. Shi, and Z.H. Duan Microarray gene expression profiling and analysis in renal cell carcinoma BMC Urol 4 2004 9
11. H. Zhao, B. Ljungberg, and K. Grankvist Gene expression profiling predicts survival in conventional renal cell carcinoma PLoS Med 3 2006 e13
12. E. Hirota, L. Yan, and T. Tsunoda Genome-wide gene expression profiles of clear cell renal cell carcinoma: identification of molecular targets for treatment of renal cell carcinoma Int J Oncol 29 2006 799 827
13. M.H. Bui, D. Seligson, and K.R. Han Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy Clin Cancer Res 9 2003 802 811
14. G.C. Brito, A.A. Fachel, and A.L. Vettore Identification of protein-coding and intronic noncoding RNAs down-regulated in clear cell renal carcinoma Mol Carcinog 47 2008 757 767
15. J. Kononen, L. Bubendorf, and A. Kallioniemi Tissue microarrays for high-throughput molecular profiling of tumor specimens Nat Med 4 1998 844 847
16. E. Bruder, O. Passera, and D. Harms Morphologic and molecular characterization of renal cell carcinoma in children and young adults Am J Surg Pathol 28 2004 1117 1132
17. L.H. Sobin, C. Wittekind, and International Union Against Cancer TNM Classification of Malignant Tumours 6th ed. 2002 Wiley-Liss New York xxiii, 239 p
18. K.L. Henriksen, B.B. Rasmussen, and A.E. Lykkesfeldt Semi-quantitative scoring of potentially predictive markers for endocrine treatment of breast cancer: a comparison between whole sections and tissue microarrays J Clin Pathol 60 2007 397 404
19. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
20. Y. Mizutani, H. Nakanishi, and K. Yamamoto Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significance J Clin Oncol 23 2005 448 454
21. J.S. Lam, O. Shvarts, and J.T. Leppert Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy J Urol 173 2005 1853 1862
22. J. Li, and J. Yuan Caspases in apoptosis and beyond Oncogene 27 2008 6194 6206
23. N.A. Thornberry, and Y. Lazebnik Caspases: enemies within Science 281 1998 1312 1316
24. F. Palmerini, E. Devilard, and A. Jarry Caspase 7 downregulation as an immunohistochemical marker of colonic carcinoma Hum Pathol 32 2001 461 467
25. G. Rodriguez-Berriguete, L. Galvis, and B. Fraile Immunoreactivity to caspase-3, caspase-7, caspase-8, and caspase-9 forms is frequently lost in human prostate tumors Hum Pathol 43 2012 229 237
26. V. Kolenko, R.G. Uzzo, and R. Bukowski Dead or dying: necrosis versus apoptosis in caspase-deficient human renal cell carcinoma Cancer Res 59 1999 2838 2842
27. Hudson RS, Yi M, Esposito D, et al. MicroRNA-106b-25 cluster expression is associated with early disease recurrence and targets caspase-7 and focal adhesion in human prostate cancer [e-pub ahead of print]. Oncogene. doi: 10.1038/onc.2012.424, accessed February 22, 2012.
28. M.F. Dall'Oglio, L.A. Ribeiro-Filho, and A.A. Antunes Microvascular tumor invasion, tumor size and Fuhrman grade: a pathological triad for prognostic evaluation of renal cell carcinoma J Urol 178 2007 425 428 discussion 428
29. P.I. Karakiewicz, A. Briganti, and F.K. Chun Multi-institutional validation of a new renal cancer-specific survival nomogram J Clin Oncol 25 2007 1316 1322
30. J. Plati, O. Bucur, and R. Khosravi-Far Apoptotic cell signaling in cancer progression and therapy Integr Biol (Camb) 3 2011 279 296